BIODIEM LIMITED (BDM)

Commercialisation of biotechnology research.

On this page you will find:

Company snapshot Delayed share price Company announcements Price history chart Exchange Traded Options

Company details Closing prices Dividends Warrants & Structured Products ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code	Last	% Chg	Bid	Offer	Open	High	Low	Vol
BDM	0.034	-2.86%	0.033	0.035	0.034	0.034	0.034	195,000

BIODIEM LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code	BDM
Securities	ASX Code, Security Description ------------------------------ BDM, Ordinary Fully Paid BDMO, Option Expiring 31-dec-2014
Official Listing Date	28 January, 2004
GICS Industry Group	Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign?	No
Internet Address	http://www.biodiem.com/
Registered Office Address	Suite 3 Level 11, 470 Collins Street, MELBOURNE, VIC, AUSTRALIA, 3000
Head Office Telephone	(03) 9613 4100
Head Office Fax	(03) 9613 4111
Share Registry	COMPUTERSHARE INVESTOR SERVICES PTY LIMITED YARRA FALLS, 452 JOHNSTON STREET, ABBOTSFORD, VIC, AUSTRALIA, 3067
Share Registry Telephone	1300 787 272

Directors / Senior Management
Mr Hugh Morgan (Chairman, Director) Ms Julie Phillips (CEO) Mr Don Brooks (Non Exec. Director) Prof. Arthur Li (Non Exec. Director) Prof. Larisa Rudenko (Non Exec. Director) Mr John Rawling (CFO)

Company Secretary	Ms Melanie Leydin
Principal Activities	Commercialisation of biotechnology research.

BIODIEM LIMITED announcements

How are company announcements published on www.asx.com.au?

Date	Price sens.	Headline	Pages	PDF
19/06/2013		BioDiem's Asia Biotech Invest 2013 video presentation	1	PDF
04/06/2013		Asia Biotech Investor Presentation 2013	30	PDF
22/05/2013		New Japanese protozoal patent for BDM-I	2	PDF
10/05/2013		BDM-I progress in NIH Research Program as Fungal Infection T	2	PDF
30/04/2013		Appendix 4C - quarterly	5	PDF
19/04/2013		ALSIS Presentation April 2013	29	PDF
05/04/2013		Van Leeuwenhoeck Research publishes updated analyst report	2	PDF
20/03/2013		BioPharma Asia presentation March 2013	22	PDF
21/02/2013		Additional Antimicrobial Patent Granted in China	2	PDF
21/02/2013		Half Yearly Report and Accounts	21	PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date	Last	% Change	High	Low	Vol *
17 Jun 2013	0.035	-5.41%	0.035	0.035	107,030
14 Jun 2013	0.037	5.71%	0.037	0.037	15,000
05 Jun 2013	0.035	0%	0.035	0.035	42,970
04 Jun 2013	0.035	6.06%	0.035	0.035	50,000
03 Jun 2013	0.033	0%	0.033	0.033	164,294

* Volume of shares shown represents only those shares traded on ASX.

BIODIEM LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BDM. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BDM

Warrants & Structured Products

No warrants & Structured Products are available over the security BDM

ASX CFDs

No Contracts For Differences are available over the security BDM

MyASX: Login | Sign up